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Summary.-The transplantability of a xenografted human adenocarcinoma has
been examined in mice that had been immune-suppressed by thymectomy and
whole-bodyirradiation and the results have beencompared withtransplantation into
athymic (nude) mice. Two alternative techniques were used to prevent marrow
failure following whole-body irradiation: reconstituting the animals with a
marrow graft, or protecting them by an injection of cytosine arabinoside (Ara-C)
2 days before the irradiation. The results show that the Ara-C-prepared mice were
more receptive to transplantation than marrow-grafted or nude mice, and they were
the only animals that developed regional metastases from implanted xenografts.
Some recovery of immunity occurred in both types of immune-suppressed mice,
which was evident more than 5 weeks after immune-suppression and which was
more marked in females than in males. It was concluded that the immune-sup-
pressed mice were superior to nude mice for short-term experiments but they
may be less satisfactory for long-term experiments.
DURING the past 5 years we have been
engaged in a programme of research on
the growth and response to treatment of
human tumours grafted into immune-
suppressed mice. The results that we have
published so far (Pickard, Cobb and Steel,
1975; Kopper and Steel, 1975; Courtenay
et al., 1976) were obtained with mice that
had been immune-suppressed by a stan-
dard technique of thymectomy, whole-
body irradiation, and marrow reconstitu-
tion. Within the past 18 months we have
explored methods of improving the level
of immune suppression, and this paper
describes our results.
MATERIAL AND METHODS
Original method of immune suppression.-
The original technique involved thymectomy
at 3-4 weeks of age. Male and female mice of
the Institute of Cancer Research colony of
CBA/lac mice were used, and have continued
to be employed throughout the work des-
cribed here. The thymectomy was performed
under ether anaesthesia. The mouse was
laid out in a supine position, head towards the
operator, and a 5-7 mm incision was made
in the skin overlying the suprasternal
notch. The neck muscles were pulled apart
with 2 pairs of forceps and the sternum
was split to a distance of 3 mm using sharp-
pointed scissors. The 2 lobes of the thymus
could then be easily seen and were quickly
sucked out through a glass tube connected
via a glass collecting-chamber to a rotary
vacuum pump. Finally, the skin was closed
with a single metal Michel clip, and the
animal was immediately placed in a warm box
while it recovered from the anaesthetic. A
skilled operator could perform a thymectomy
by this technique in about 1 min, with an
operative mortality of less than 500.
Two weeks after thymectomy the mice
were given 900 rad whole-body irradiation
from a 60Co source, and on the same day they
received an i.v. injection ofsyngeneic marrow
cells. The standard inoculum of nucleated
marrow cells was in excess of 5 x 106.
Marrow from non-thymectomized donors
was used, on the basis of the work of Miller,
Doak and Cross (1963). Tumour implantation
was usually performed 2-4 weeks after
reconstitution.IMMUNE-SUPPRESSION TECHNIQUES
This standard procedure formed the basis
of all our early work in this area. It provided
mice that allowed over 30 human tumours to
be successfully grafted and in some cases
repeatedly transplanted for up to 20 passages.
Effect of the size of the marrow graft.-Our
suspicions that the immune-suppression tech-
nique was not optimal were raised by the
observation that the receptivity of mice to
xenografting varied from one operator to
another, and that it appeared to depend
upon the number of marrow cells used for
reconstitution of the lethally irradiated mice.
For the present work we selected 2 lines of
human tumour xenografts as our standard
transplantation test svstems. Most of the
work has been performed on a passaged
tumour line that was originally started by
Dr R. G. Pickard in 1973. The tumour came
from a male patient who was found at opera-
tion to have widespread metastases within
the peritoneum, which in the opinion of the
surgeon originated from a large mass in the
pancreas. The histopathological appearance
was ofa poorly differentiated adenocarcinoma
that was consistent with carcinoma of the
pancreas but which did not allow a conclusive
diagnosis. After a long period of "silent"
growth in the first passage this xenograft
has grown quickly, and can be prepared as a
cell suspension on enzyme treatment with
collagenase and trypsin. The cells give a high
plating efficiency when cultured in soft agar
and this tumour was therefore used for the
radiobiological studies reported by Courtenay
et al. (1976). This xenograft has now been
designated HX32 and the number of HX32
cells required for intramuscular takes has
been used as an index of the level of immune
suppression of recipient mice. Tumours used
in the present studies were in their 12th to
21st passages in immune-suppressed mice.
RESULTS
Table I shows the proportion of tumour
takes following the implantation of 105
HX32 tumour cells in mice that had been
reconstituted with different numbers of
marrow cells. The proportion of takes
increased as the number of grafted
marrow cells was reduced, suggesting
that the grafted marrow may be partly
responsible for the regeneration of im-
munity. The mice reconstituted with
TABLE I.-Proportion of Takes Following
Implantation of 105 HX32 Cells in Mice
Reconstituted with Different Numbers of
Marrow Cells
Number of
grafted
marrow
cells
5 x 106
1 X 106
2 x 105
1st Expt.
3/20
5/20
14/20
2nd Expt.
15/40
27/40
26/36
Total
18/60
32/60
40/56
2 x 105 marrow cells survived subsequent
manipulations just as well as those
reconstituted with a larger graft. We
conclude that 5 x 106 marrow cells is
grossly in excess of the number required
to reconstitute mice that have received
900 rad whole-body irradiation, and that
reducing the number of marrow cells to
2 x 105 improves the degree of immune
suppression.
Effect of additional treatment with cyclo-
phosphamide
Cyclophosphamide (CY) is one of the
most potent immune-suppressive agents
when given before the antigen (Hersch,
1973) and tests were therefore made ofthe
effect on the take-rate of xenografts of
retreating marrow-reconstituted immune-
suppressed mice with CY shortly before
implantation. The mice in these experi-
ments were reconstituted with 5 x 106
marrow cells. Various xenograft lines were
used and in each case a modest improve-
ment in take-rate seemed to be associated
with the CY pretreatment. As an example,
mice were given i.m. injections of a brei
ofHX32 tumour tissue, made by chopping
the tissue finely, mixing it with 10 vols of
tissue culture medium and forcing it
through needles of decreasing diameter.
When 0-1 ml volumes ofthis brei were im-
planted 2 days after the mice had received
i.p. injections of 200 mg/kg CY, the takes
increasedfrom 22/40 (55%) to 26/32 (81%).
A second example of the effect of addi-
tional immune-suppression by CY is
shown in Fig. 1. For this test we employed
a different xenograft line, the HX18
tumour described by Pickard et al. (1975)
225(. G. STEEL, V. D. COURTENAY AND A. Y. ROSTOM
-2
0
ae
Number of viable cells implanted
FIG. I. The relation between the observedl
proportion of takes and the number of
viable HX18 tumour cells implanted i.m.:
0, into nude mice; A V, 2 experiments
in marrow-reconstituted mice; O, marrow-
reconstituted mice treated with cyclo-
phosphamidle 2 (lays before implantation.
The full line is a cumulative Poisson curve
fitted to the nude-mouse data.
and Kopper and Steel (1975). For this
tumour a cell-titration experiment had
already been performed (see Chart 3 in
Kopper and Steel, 1975) which showed that
105 HX 18 cells were required to produce
5000 tumour takes when implanted i.m.
into mice that had been reconstituted with
5 x 106 marrow cells. The addition of 106
lethally irradiated HX18 cells to each
inoculum had little effect on the take-rate
of viable cells. This experiment was
repeated using 3 groups of mice: the main
group was thymectomized, irradiated and
reconstituted with 5 x 106 marrow cells
as described above; 10 of these mice were
pretreated 2 days before tumour im-
plantation with 240 mg/kg CY; 40 athymic
(nude) mice were obtained from the
Institute ofCancer Research colony which
has been random-bred for 2 years from
stock obtained from the Laboratory
Animals Centre, Carshalton, Surrey.
A suspension ofHX18 cells was prepared
and implanted i.m. into these mice using
various numbers of tumour cells. As can
be seen from Fig. 1, the immune-sup-
pressed, non-pretreated mice gave take-
rates that agreed well with the earlier data
of Kopper and Steel. The mice given CY
pretreatment and 105 HX 18 cells gave a
higher take-rate, but not as good as that
found in the nude mice. The full line in
Fig. 1 is a cumulative Poisson distribution
fitted to the results in nude mice. WNhile the
data for nude mice are consistent with
this theoretical distribution, the results on
the immune-suppressed mice follow a
much flatter curve. The most likely
explanation of this is that the immune-
suppressed mice were variable in their
receptivity to HX18 grafting.
It was concluded that a modestimprove-
ment in take-rate in immune-suppressed
mice could be achieved by additional
treatment with CY injected -2 days
before tumoUr implantation.
IJmnaune deprivation with Ara-C protection
A second approach to the improvement
of the level of immune-suppression has
arisen out ofthe work ofDrJ. L. Millarand
Dr N. M. Blackett in this Institute. They have found that a number of cytotoxic
agents can protect mice from subsequent
treatment with whole-body radiation or
alkylating agents (Millar, Hudspith and
Blackett, 1975; Millar, 1976). Forexample,
cytosine arabinoside (Ara-C) given 2 days before whole-body irradiation makes the
mice tolerant to an otherwise lethal dose
of over 1000 rad. This effect is not due to
Ara-C reducing the damage to marrow
stem-cells (whose survival as a result of
irradiation is not changed by the pre-
treatment) but to enhanced recovery of
the marrow, and perhaps also of the
intestinal epithelium.
The attraction of this approach is that
it provides a way of giving mice a large dose of whole-body irradiation without
the need for marrow reconstitution. Since
the marrow that is used to reconstitute
mice probably contains T cells or their
precursors, the elimination of the need
for a graft might give better immune-
suppression.
A series of cell-titration experiments
was performed, using HX32 tumour cells
to test the receptivity of different types of
mouse to i.m. tumour transplantation, the
tumour cells being implanted within 4
weeks of irradiation. These experiments employed mice reconstituted with 2 x 105
marrow cells, Ara-C-prepared mice, and
some nude mice for comparison. The
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FiIG. 2. The relation between the observed
proportion of takes and the number of
viable HX32 tumour cells implanted i.m.:
0, into nude mice; A, into marrow-
reconstituted mice; O, into Ara-C-pre-
pared mice. The upper diagram is for the
implantation of viable tumour cells alone.
In the lower diagram each implant con-
tained 106 lethally irradiated tumour cells
in addition to the viable cells.
results are shown in Fig. 2. The experi-
ments were performed on female mice,
with and without the addition of 106
lethally irradiated tumour cells to each
inoculum in order to investigate their
value in improving the take-rate (Revesz,
1958). In this case, the 2 types of immune-
suppressed mice always produced as
many or more positive takes than were
found in nude mice given the same number
of tumour cells. In the Ara-C-prepared
and nude mice, the number of viable
tumour cells required for a given per-
centage of takes was less by a factor of
10-100 when lethally irradiated tumour
cells were added than when they were
omitted. A comparison of all 3 types of
mouse was made only in the groups that
were given lethally irradiated cells and
here the Ara-C-prepared mice were more
receptive to transplantation than the
marrow-reconstituted or nude mice.
Studies of the time of appearance of the
tumours showed that the early growth of
implants in both types of immune-
suppressed mice was associated with a
similar doubling time of the tumour cells.
Persi8tence of the level of immune suppres-
sion
Experiments involving xenografted
tumours often last many weeks, and it is
important therefore to examine not only
the level of immune suppression achieved
but also its persistence. This has been
studied in the present work by keeping a
record of the take-rate in routine passages
ofthe HX32 tumour in mice prepared with
Ara-C or 2 x 105 marrow cells. The
mice received bilateral i.m. implants of
104-l05 tumour cells in suspension and
the time of implantation was varied
from 1 day to 16 weeks after irradiation.
Fig. 3 shows how the proportion of
mice developing one or more tumours
depended upon the interval between the
immune-suppressive irradiation and the
implantation of tumour cells. For the
greater part of this study thymectomy
was performed at 4 weeks of age and
irradiation was given 2 weeks later.
Altogether, the results from 383 mice are
included in this chart, which shows no
significant difference between the take-
rate for marrow-reconstituted or Ara-C-
treated mice. Adding the results from both
methods of preparation, tumour growth
occurred in 218/227 mice when implants
were made up to 5 weeks after irradiation.
Thereafter the take-rate fell to reach a
level of about 10-4000 beyond the 9th
week. The results obtained from male and
female mice show that the take-rate for
males remained rather higher than that
for females.
The effect of changing the interval
between thymectomy and irradiation has
also been examined. Male mice were kept
for periods up to 20 weeks after thymec-
tomy; the irradiation was then given
using Ara-C protection and the implanta-G. G. STEEL, V. D. COURTENAY AND A. Y. ROSTOM
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TABLE II.-Lack of Effect of Delay
between Thymectomy snd Vhole-body
Irradiation on the Take-rate of HX32
Cells in Ara-C-protected Male Mice
Interval Interval between irradiation*
between and tumour implantation
thymectomy (weeks)
and irradia- , -
(weeks) Less than 1 1-2 2-3 5
0-8 14/14 31/32 9/9
8-12 11/11 5/5 5/5
12-16 5/5 25/26 6/7
16-20 5/5 7/9 5/5
Weeks after irradiation
FIG. 3. Proportion of takes observed when
marrow-reconstituted or Ara-C-prepared
mice were given bilateral implants of
104-105 HX32 tumour cells at various
times after immune-suppressive irradiation.
Thymectomy was , 4 weeks before irra-
diation. O, implants into female mice; A,
implants into male mice.
tion was performed up to 5 weeks later.
There was a consistently high take-rate,
indicating that a delay between thymec-
tomy and irradiation did not prevent the
irradiation from being fully effective in
inducing immune suppression (Table II).
On the basis of these data our standard
procedure is now to hold mice in stock
after thymectomy at 3-4 weeks of age and
then to complete the preparation by
giving Ara-C and irradiation a few days
before they are required for transplanta-
tion.
Metastasis of xenografts in Ara-C-pre-
treated mice
Spontaneous metastasis of xenografts
had not been seen in our laboratory until
the present programme using Ara-C-
pretreated mice was begun. Our colleague,
Dr Robert George, performed a series of
experiments in which HX32 cells were
injected i.v. into mice that had been
reconstituted with 5 x 106 marrow cells,
and he failed to detect the formation of
lung colonies.
However, since our change from marrow
reconstitution to Ara-C protection, meta-
stases have been observed in mice with
large bilateral i.m. HX32 tumours. These
were killed when the tumours measured
Total 128/133 (96%)
* Preceded 2 (lays earlier by 200 mg/kg Ara-C.
-2 cm diameter (20-23 days after im-
plantation). Five out of 10 mice that
had been immune-suppressed using Ara-C
developed one or more enlarged lymph
nodes in the lower para-aortic region. On
histological examination, these nodes were
found to be partially or completely
replaced by tumour tissue. Ten mice
prepared by marrow reconstitution (2 x
105 cells) and 18 nude mice that were killed
with large tumours failed to show histo-
logical evidence of lymph-node or lung
involvement. When suspensions contain-
ing 5-7 x 105 HX32 tumour cells were
injected i.v. into Ara-C-pretreated mice,
8/15 mice developed lung tumours.
DISCUSSION
Thispreliminaryreportofourexperience
with improved methods of immune-sup-
pression has shown that the use of
200 mg/kg of Ara-C followed 2 days later
by 900 rad whole-body irradiation is a
promising new technique. The cell-titra-
tion experiments (Fig. 2) indicate that
when viable tumour cells were implanted
in the presence of an excess of lethally
irradiated cells, the mice prepared using
Ara-C were at least as receptive as mice
prepared using the minimum number of
grafted marrow cells. We have also shown
that the widely used practice ofreconstitu-
ting with 5 x 106 marrow cells may in part
counteract the immune suppression in-
duced by the whole-body irradiation.
Reducing the marrow graft 25-fold to
2 X 105 has, in our hands, given a useful
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improvement in transplantability, perhaps
by reintroducing fewer T-cells or T-cell
precursors. Both immune-suppressive
techniquies yielded mice that were more
receptive to transplantation than athymic
(nude) mice. In preliminary experiments
we have found that treatment with
cyclophosphamide shortly before implan-
tation also improved transplantability
but, since these experiments were per-
formed on mice that were suboptimally
suppressed, further work is necessary to
confirm the value of this procedure.
The techniques of immune deprivation
that we have used clearly do not confer
long-lasting immune suppression. Our
data (Fig. 3) indicate that there was a
period of 5 weeks after immune sup-
pression when the receptivity of the mice
to grafting was good. The subsequent loss
of receptivity was more marked in female
than in male mice. The length of the
period ofhigh receptivity might be shorter
if a more sensitive test had been used
(i.e. a smaller inoculum of tumour cells).
With a less sensitive test the period might
be longer. This loss ofimmune suppression
may be a serious problem in some types of
work with xenografted tumours. It may,
for instance, help to explain the low take-
rate of many primary human tumour
xenografts in immune-suppressed mice, if
their growth rate was insufficient to beat
the returning host immunity. In a series
of tumour-control experiments with the
HX32 tumour we have found no recur-
rences beyond the 6th week, as iftumours
that suffered a large reduction in cell
numbers were more likely to be over-
whelmed by the host response. We are at
present exploring methods of re-inducing
the immune suppression.
The effect of lethally irradiated cells in
improving the take-rate of viable tumour
cells is a well-described phenomenon
(Revesz, 1958). It has been claimed by
Peters and Hewitt (1974) to be due to the
induction of a local clotting mechanism
that prevents the escape of viable cells
from the implantation site and their
subsequent exposure to systemic host
defence mechanisms. Their action in also
swamping local defence mechanisms can-
not be ruled out. In the present experi-
ments the addition of lethally irradiated
cells significantly improved the take-rate
of the HX32 xenograft line. We are
inclined to attribute our earlier failure to
observe this effect with the HX18 line
(Kopper and Steel, 1975) to the fact that
the mice used at that time were subopti-
mally immune-suppressed.
The incidence of local and distant
metastases in mice prepared by Ara-C
protection is encouraging, and this pheno-
menon is now being studied in more detail.
In conjunction with the higher take-rates,
it leads us to believe that the Ara-C tech-
nique is a useful new method of immune
suppression. By eliminating the need for
a marrow graft it has the advantage of
technical simplicity, and not unimportant
is the fact that, in this Institute, the cost
of breeding and preparing immune-sup-
pressed mice is now about one-quarter of
the cost ofnude mice. Such considerations
are, ofcourse, secondary to the question of
whether the mice are satisfactory hosts
for the study ofthe growth and treatment
response of human tumours, and in our
judgement the choice between immune-
suppressed and nude mice is from this
standpoint still an open one. The present
work suggests that for relatively short-
term experiments, for instance those
involving cell-survival measurements
(Courtenay et al., 1976), the immune-
suppressed mice may be superior, while
for long-term experiments the nude mice
have the advantage.
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